qualityassurance
★    

2024-10-30 14:47
(180 d 04:46 ago)

Posting: # 24250
Views: 1,578
 

 Shipment of Investigational Medicinal products [Regulatives / Guidelines]

Hello experts,

RLD (from EMA) label claims "This medicinal product does not require any special storage conditions". Winter is going on in Europe and maximum temperature is below 20°C at both locations (shipper and consignee).

Can we ship RLD via DHL (without temperature controlled shipment) from supplier to sponsor by just keeping the datalogger during the transportation considering that temperature excursion above 40°C (accelerated stability condition) will not occur. RLD will be used in BE study. Same question for the shipment of IMPs from sponsor to CRO.

Regards,
QA
Ohlbe
★★★

France,
2024-11-05 23:11
(173 d 20:21 ago)

@ qualityassurance
Posting: # 24261
Views: 1,139
 

 Shipment of Investigational Medicinal products

Dear QA,

❝ RLD (from EMA) label claims "This medicinal product does not require any special storage conditions". Winter is going on in Europe and maximum temperature is below 20°C at both locations (shipper and consignee).


Not yet winter, please... Give us some more mild and sunny Autumn days !

❝ Can we ship RLD via DHL (without temperature controlled shipment) from supplier to sponsor by just keeping the datalogger during the transportation considering that temperature excursion above 40°C (accelerated stability condition) will not occur. RLD will be used in BE study. Same question for the shipment of IMPs from sponsor to CRO.


I would not find it shocking, if there are no specified storage conditions. In any case if the temperature is monitored by data loggers you will be able to quarantine the products when received, and if needed, to replace them in case of temperature excursion (what I would be worried about when winter really comes is freezing temperatures). Strictly no risk for the trial participants. Only risk for the sponsor: having to buy some reference product again, and loosing some time. Their problem.

Regards
Ohlbe
qualityassurance
★    

2024-11-06 15:15
(173 d 04:18 ago)

@ Ohlbe
Posting: # 24263
Views: 1,071
 

 Shipment of Investigational Medicinal products

Dear Ohlbe,

❝ Not yet winter, please... Give us some more mild and sunny Autumn days !

Ohh! My bad!! Enjoy the last few sunny Autumn days :ok:

❝ I would not find it shocking, if there are no specified storage conditions. In any case if the temperature is monitored by data loggers you will be able to quarantine the products when received, and if needed, to replace them in case of temperature excursion (what I would be worried about when winter really comes is freezing temperatures).

:ok:

❝ Strictly no risk for the trial participants.❝

Indeed. as long as temperature does not cross 40 degree during transportation

❝ Only risk for the sponsor: having to buy some reference product again, and loosing some time. Their problem.

Yes. Taking risk when RLD is not costly and have enough timeline.

Extremely sorry for very bad formatting. [No problem; corrected. Helmut]

Regards,
QA
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
94 visitors (0 registered, 94 guests [including 5 identified bots]).
Forum time: 20:33 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5